AI Article Synopsis

  • Acanthosis nigricans (AN) is a skin condition linked to insulin resistance, endocrine issues, certain medications, chromosomal abnormalities, and sometimes cancers, particularly abdominal neoplasms.
  • Malignant AN typically affects older patients, showing early subtle symptoms and primarily manifests in skin folds like the armpits and neck.
  • A case study is presented involving a woman with significant weight loss and skin darkening, leading to the discovery of a renal cell carcinoma (RCC) after finding a tumor in her flank, highlighting the connection between AN and RCC.

Article Abstract

Acanthosis nigricans (AN), an entity recognized since the 19th century, is a dermatopathy associated with insulin-resistant conditions, endocrinopathies, drugs, chromosome abnormalities and neoplasia. The latter, also known as malignant AN, is mostly related to abdominal neoplasms. Malignant AN occurs frequently among elderly patients. In these cases, the onset is subtle, and spreading involves the flexural regions of the body, particularly the axillae, palms, soles, and mucosa. Gastric adenocarcinoma is the most frequent associated neoplasia, but many others have been reported. Renal cell carcinoma (RCC), although already reported, is rarely associated with malignant AN. The authors report the case of a woman who was being treated for depression but presented a long-standing and marked weight loss, followed by darkening of the neck and the axillary regions. Physical examination disclosed a tumoral mass in the left flank and symmetrical, pigmented, velvety, verrucous plaques on both axillae, which is classical for AN. The diagnostic work-up disclosed a huge renal mass, which was resected and further diagnosed as a RCC. The post-operative period was uneventful and the skin alteration was evanescent at the first follow-up consultation. The authors call attention to the association of AN with RCC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880432PMC
http://dx.doi.org/10.4322/acr.2016.021DOI Listing

Publication Analysis

Top Keywords

acanthosis nigricans
8
renal cell
8
cell carcinoma
8
associated
4
nigricans associated
4
associated clear-cell
4
clear-cell renal
4
carcinoma acanthosis
4
nigricans entity
4
entity recognized
4

Similar Publications

Objective: Incorporate sleep into a novel lifestyle intervention strategy in adolescents with Emerging symptoms of polycystic ovary syndrome (E-PCOS).

Design: A single-center cohort study.

Setting: University hospital-based clinic for adolescents with PCOS.

View Article and Find Full Text PDF

Background: Online digital materials are integral to patient education and health care outcomes in dermatology. Acanthosis nigricans (AN) is a common condition, often associated with underlying diseases such as insulin resistance. Patients frequently search the internet for information related to this cutaneous finding.

View Article and Find Full Text PDF

Combinational treatment approaches for acanthosis nigricans: a review.

Arch Dermatol Res

January 2025

Fixderma India Pvt Ltd, Sector 54, Gurgaon, 122011, Haryana, India.

Acanthosis Nigricans is characterised by hyperpigmented, hyperkeratotic, dark, rough patches or plaques distributed in intertriginous areas. Hyperkeratosis is the main concern that leads to the darkening of the skin. Numerous treatment options are available.

View Article and Find Full Text PDF

Large Nevus Lipomatosus Cutaneous Superficialis in the Skin of Color.

Skinmed

January 2025

Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Montefiore Hospital, Bronx, NY.

A 15-year-old African-American man (Fitzpatrick skin type V) presented to the outpatient dermatology clinic with a large, verrucous, exophytic mass measuring 3.5 × 2.3 cm on the right lateral side of the posterior flank (Figure 1).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!